Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 71335-1725

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 71335-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine Hydrochloride And Naloxone Hydrochlo 1)

Buprenorphine Chemical Structure (Buprenorphine Hydrochloride And Naloxone Hydrochlo 1)
Chemical structure of Buprenorphine Hydrochloride, the active ingredient in the sublingual tablet containing Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate by Bryant Ranch Prepack.*
FDA Label Image

Naloxone Chemical Structure (Buprenorphine Hydrochloride And Naloxone Hydrochlo 2)

Naloxone Chemical Structure (Buprenorphine Hydrochloride And Naloxone Hydrochlo 2)
Chemical structure of buprenorphine hydrochloride dihydrate, showing its molecular framework including hydroxyl and ketone functional groups, a nitrogen-containing ring, and hydrate (HCl ยท 2H2O) association.*
FDA Label Image

Mouth (Buprenorphine Hydrochloride And Naloxone Hydrochlo 3)

Mouth (Buprenorphine Hydrochloride And Naloxone Hydrochlo 3)
An instructional black-and-white illustration showing a person placing a sublingual tablet under their tongue. The image focuses on the open mouth with the tablet positioned near the lower teeth and tongue.*
FDA Label Image

Label (Lbl713351725)

Label (Lbl713351725)
Label for Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/2 mg sublingual tablets, packaged by Bryant Ranch Prepack. The label indicates comparison to Suboxone 8 mg/2 mg sublingual tablets by SpecGx LLC, includes a lot number, storage instructions, and an NDC of 71335-1725-1. The tablets are described as orange hexagon, six-sided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.